SEC Form 4 · accession 0001140361-16-048701
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chad Kugler
Officer — Sr. VP of R&D
Period of report
Jan 22, 2016
Accepted (ET)
Jan 26, 2016 · 4:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 22, 2016 | A | 11,914 | — | A | 56,872 | D | |
| Common StockF1 | holding | — | — | — | 44,958 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Increase from last filing represents 663 shares acquired under the Vascular Solutions Stock Purchase Plan for the period ending April 30, 2015 at $25.00/share; and 187 shares acquired under the plan for the period ending October 31, 2015 at $25.00/share.
- F2Represents restricted stock award that shall vest over four years at the rate of 50% on the second anniversary date of the award and 25% on each anniversary date thereafter; subject to continued employment.